TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile
When do Tobramycin Sulfate In Sodium Chloride 0.9% In Plastic Container patents expire, and what generic alternatives are available?
Tobramycin Sulfate In Sodium Chloride 0.9% In Plastic Container is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is tobramycin sulfate. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tobramycin Sulfate In Sodium Chloride 0.9% In Plastic Container
A generic version of TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER was approved as tobramycin sulfate by HIKMA on April 26th, 1991.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What are the global sales for TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
Summary for TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 5 |
| DailyMed Link: | TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Madonna Magdy Fahmy | Early Phase 1 |
| Joint Purification Systems | Phase 2 |
| Osteal Therapeutics, Inc. | Phase 2 |
See all TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | tobramycin sulfate | INJECTABLE;INJECTION | 063081-003 | Jul 31, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | tobramycin sulfate | INJECTABLE;INJECTION | 063081-006 | Jun 2, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | tobramycin sulfate | INJECTABLE;INJECTION | 063081-001 | Jul 31, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
